The ground seems to be ready for a defense for humans against the coronavirus pandemic. Moderna Inc.’s vaccine candidate protected 16 monkeys in a trial. Its result in 30,000 humans is awaited, reported livemint.
Two injections of the vaccine protected against heavy exposure to the virus at two different levels of dosage, Moderna said in findings published on Tuesday in the New England Journal of Medicine, reported livemint.
The results on primates
The results, if they hold up in humans, suggest that the vaccine may be able to protect against Covid-19 in both the upper and lower airways, reported livemint quoting the study.
Phase 3 trial to determine the safety and efficacy of the vaccine will begin producing data in November or December. The U.S. government is providing $955 million to help fund the vaccine’s development.
Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, which is $11 more than another vaccine from Pfizer Inc and BioNTech, livemint quoted Financial Times as reporting on Tuesday, citing unnamed sources.
Bhadrak: A woman from Gujarat allegedly consumed phenyl in an attempt to kill herself inside…
Mumbai: After several hurdles and controversies, actor-turned-politician Kangana Ranaut’s political drama ‘Emergency' is running in…
Bhubaneswar: Ahead of Donald Trump's swearing-in ceremony, business tycoon Mukesh Ambani and his wife Nita…
Bhubaneswar: Around 50 people were stranded in Odisha's Chilika lake as the boat ferrying them…
Bhubaneswar: The two-day 3rd National Mining Ministers’ Conference will begin at Konark in Odisha on…
Deogarh: Five children were hospitalised as they fell ill after consuming fertiliser mistaking it as…
This website uses cookies.
